---
title: "Albertsons Companies 10-K: $83.17B Revenue, $0.40 EPS (Adjusted $2.18)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284267672.md"
description: "Albertsons Companies reported fiscal-year net sales of $83.17 billion, with a diluted net income per Class A common share of $0.40, and adjusted diluted net income per share of $2.18, excluding a significant opioid-related charge. Revenue increased by 3.5% year-over-year, driven by a 2.0% identical sales rise and an extra week. The company faced a $599.8 million opioid settlement charge, impacting net income, which totaled $217.4 million. Digital sales grew 21%, and loyalty membership rose 12% to 51.2 million. The company completed 94 remodels and opened 9 new stores during the period."
datetime: "2026-04-27T20:35:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284267672.md)
  - [en](https://longbridge.com/en/news/284267672.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284267672.md)
---

# Albertsons Companies 10-K: $83.17B Revenue, $0.40 EPS (Adjusted $2.18)

Albertsons Companies reported fiscal-year net sales of $83.17 billion and diluted net income per Class A common share of $0.40, with adjusted diluted net income per share of $2.18 reflecting exclusion of a significant opioid-related charge. Revenue rose 3.5% year-over-year, driven by a 2.0% identical sales increase and an extra 53rd week, while reported net income was reduced by a $599.8 million net-of-tax opioid settlement charge. Gross margin totaled $22.61 billion (27.2% rate) and operating income was $727.6 million for the period.

**Financial Highlights**

-   **Net sales and other revenue**: $83,172.5 million, up $2,781.6 million (3.5%) versus prior year (included a 53rd week; 2.0% identical sales).
-   **Gross margin**: $22,606.7 million; gross margin rate 27.2% (down 59 basis points ex-fuel/LIFO, impacted by pharmacy mix and digital costs).
-   **Operating income**: $727.6 million; operating margin 0.9%, decreased versus prior year reflecting lower Adjusted EBITDA and the impact of the opioid charge.
-   **Net income**: $217.4 million, which includes a $599.8 million net-of-tax opioid settlement charge; adjusted net income $1,209.3 million.
-   **Diluted net income per Class A common share**: $0.40; adjusted diluted net income per share $2.18.

**Business Highlights**

-   **Revenue drivers and channels**: Digital sales grew 21%, supporting curbside pickup, home delivery and broader omni-channel engagement.
-   **Loyalty and customer engagement**: Loyalty membership increased 12% to 51.2 million, enhancing frequency, targeted promotions and personalization efforts.
-   **Pharmacy and margin mix**: Pharmacy sales expanded but exerted downward pressure on gross margin mix; delivery/handling and investments in value programs also compressed margins.
-   **Store operations and remodels**: Completed 94 remodels and opened 9 new stores, operating a total of 2,244 stores during the period.
-   **Technology and operations**: Expanded AI-enabled forecasting and the Gateway platform to bolster supply chain and inventory management.

Original SEC Filing: Albertsons Companies, Inc. \[ ACI \] - 10-K - Apr. 27, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [ACI.US](https://longbridge.com/en/quote/ACI.US.md)
- [XLP.US](https://longbridge.com/en/quote/XLP.US.md)
- [IYK.US](https://longbridge.com/en/quote/IYK.US.md)

## Related News & Research

- [Albertsons Companies Announces AI-Powered Supply Chain Tool to Further Enhance Produce Quality Control and Consistency | ACI Stock News](https://longbridge.com/en/news/286266972.md)
- [BJ's (BJ) Reports Earnings Tomorrow: What To Expect](https://longbridge.com/en/news/286996748.md)
- [U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain | VTRS Stock News](https://longbridge.com/en/news/286767621.md)
- [Costco Wholesale Corporation $COST Shares Acquired by Larson Financial Group LLC](https://longbridge.com/en/news/286897506.md)
- [Baron & Budd Finalizes $774 Million Settlement With Albertsons in Nationwide Opioid Litigation](https://longbridge.com/en/news/283231102.md)